Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)
0.8296 -0.0003 (-0.04%) 14:49 ET [NASDAQ]
0.8263 x 100 0.8377 x 100
Realtime by (Cboe BZX)
0.8263 x 100 0.8377 x 100
Realtime - - (-) -
Quote Overview for Fri, Mar 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8108
Day High
0.8542
Open 0.8479
Previous Close 0.8299 0.8299
Volume 79,863 79,863
Avg Vol 311,459 311,459
Stochastic %K 6.32% 6.32%
Weighted Alpha -83.65 -83.65
5-Day Change -0.0115 (-1.36%) -0.0115 (-1.36%)
52-Week Range 0.7820 - 4.7000 0.7820 - 4.7000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,198
  • Shares Outstanding, K 43,617
  • Annual Sales, $ 112,250 K
  • Annual Income, $ -3,420 K
  • EBIT $ -1 M
  • EBITDA $ 7 M
  • 60-Month Beta 1.46
  • Price/Sales 0.37
  • Price/Cash Flow 3.51
  • Price/Book 0.54
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $-0.02 on 11/07/24
  • Next Earnings Date 03/12/25 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Computers and Technology
  • INDUSTRY GROUPING Industrial Scientific

Options Overview Details

View History
  • Implied Volatility 203.48% ( +44.45%)
  • Historical Volatility 69.84%
  • IV Percentile 68%
  • IV Rank 31.66%
  • IV High 633.92% on 02/12/25
  • IV Low 4.09% on 08/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 65
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 474
  • Open Int (30-Day) 949

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +9,989,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7820 +6.39%
on 03/04/25
Period Open: 1.4400
1.4900 -44.16%
on 02/10/25
-0.6080 (-42.22%)
since 02/07/25
3-Month
0.7820 +6.39%
on 03/04/25
Period Open: 2.2600
2.3800 -65.04%
on 12/11/24
-1.4280 (-63.19%)
since 12/06/24
52-Week
0.7820 +6.39%
on 03/04/25
Period Open: 4.5100
4.7000 -82.30%
on 04/04/24
-3.6780 (-81.55%)
since 03/07/24

Most Recent Stories

More News
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

HBIO : 0.8296 (-0.04%)
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

HBIO : 0.8296 (-0.04%)
Sidoti Events, LLC's Virtual January Micro-Cap Conference

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference...

HBIO : 0.8296 (-0.04%)
FLXS : 41.19 (+0.64%)
RECT : 4.19 (-4.77%)
ALCO : 28.53 (+1.75%)
LCFY : 6.10 (+3.39%)
ABL : 7.49 (-0.73%)
BHR : 3.04 (+1.00%)
SCWO : 0.3530 (+1.58%)
AMST : 2.37 (-1.66%)
RZLV : 1.4705 (+4.29%)
NNBR : 2.72 (+5.02%)
SBC : 3.28 (+6.18%)
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

HBIO : 0.8296 (-0.04%)
Harvard Bioscience: Q3 Earnings Snapshot

Harvard Bioscience: Q3 Earnings Snapshot

HBIO : 0.8296 (-0.04%)
Harvard Bioscience Announces Third Quarter 2024 Financial Results

HBIO : 0.8296 (-0.04%)
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

HBIO : 0.8296 (-0.04%)
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024

HBIO : 0.8296 (-0.04%)
Harvard Bioscience: Q2 Earnings Snapshot

Harvard Bioscience: Q2 Earnings Snapshot

HBIO : 0.8296 (-0.04%)
Harvard Bioscience: Q1 Earnings Snapshot

Harvard Bioscience: Q1 Earnings Snapshot

HBIO : 0.8296 (-0.04%)

Business Summary

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

See More

Key Turning Points

3rd Resistance Point 0.8897
2nd Resistance Point 0.8598
1st Resistance Point 0.8449
Last Price 0.8296
1st Support Level 0.8001
2nd Support Level 0.7702
3rd Support Level 0.7553

See More

52-Week High 4.7000
Fibonacci 61.8% 3.2033
Fibonacci 50% 2.7410
Fibonacci 38.2% 2.2787
Last Price 0.8296
52-Week Low 0.7820

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
How to Trade Futures Spreads Like a Pro – Unlock Powerful Market Insights